scispace - formally typeset
Search or ask a question

Answers from top 10 papers

More filters
Papers (10)Insight
These data suggest that AFIB is not uncommon after aortic operations but is not associated with increased morbidity, mortality, or length of hospital stay.
The results are expected to improve our understanding of the interaction between paroxysmal atrial fibrillation and sleep apnea.
Obstructive sleep apnea is common, readily diagnosed, and usually treatable.
It is likely sleep apnea is highly prevalent in patients with congestive heart failure (CHF).
A strong association between obstructive sleep apnea (OSA) and atrial fibrillation has been consistently observed in both epidemiological and clinical cohorts, and multiple studies demonstrate that OSA is associated with an increased risk of atrial fibrillation recurrence following chemical or
We conclude that there is a markedly increased prevalence of atrial fibrillation among patients with idiopathic central sleep apnea in the absence of congestive heart failure.
Open accessJournal ArticleDOI
Corinna G. Levine, Edward M. Weaver 
15 Citations
The Functional Comorbidity Index is a more robust predictor of general health status than the Charlson Comorbidity Index in obstructive sleep apnea patients.
Moreover, the high prevalence of atrial fibrillation among patients with idiopathic central sleep apnea is not explainable by the presence of hypertension or nocturnal oxygen desaturation, since both of these were more strongly associated with obstructive sleep apnea.
Open accessJournal ArticleDOI
20 Jul 2009-Circulation
109 Citations
Overall, while the evidence of sleep apnea as a causal mechanism in cardiovascular disease is strong and increasing, definitive evidence of the etiologic role of sleep apnea has yet to be obtained.
As 55% of all sleep apnea patients were found to suffer from pulmonary hypertension without any indication of a primary pulmonary or cardiac disease, the possibility that pulmonary hypertension results should not be underestimated in patients with suspected sleep apnea syndrome.

Related Questions

What are common comorbidities for sleep apnea?5 answersCommon comorbidities for sleep apnea include anxiety, depression, hypertension, dyslipidemia, asthma, cardiovascular complications (arterial hypertension, pulmonary hypertension, chronic heart failure, arrhythmias, myocardial infarction), cerebrovascular complications (strokes), metabolic complications (insulin resistance, obesity, diabetes mellitus, metabolic syndrome), gastrointestinal complications (non-alcoholic liver disease), urinary complications (chronic renal failure), neuropsychiatric complications, and a wide range of malignancies.
What is the relationship overweight and sleep apnea?4 answersOverweight and obesity are closely associated with obstructive sleep apnea (OSA). Studies have shown that there is a significant relationship between body mass index (BMI) and the severity of OSA. The risk of OSA increases with higher BMI, and individuals with obesity are more likely to have severe OSA. Furthermore, overweight and obesity have been identified as important risk factors for OSA in both adults and children. The prevalence of OSA is higher in overweight and obese individuals compared to those with normal weight. Therefore, maintaining a healthy weight is crucial in the prevention and management of OSA.
What is the relationship between obstructive sleep apnea and cognitive impairment?4 answersObstructive sleep apnea (OSA) has been associated with cognitive impairment and disorders of cognitive function. Intermittent hypoxaemia, sleep fragmentation, and changes in sleep microstructure are potential mechanisms underlying these associations. Research has shown conflicting results regarding the relationship between OSA and cognitive functioning, particularly in the older population. However, severe OSA has been associated with lower performance in processing speed and executive function in the older general population, with apolipoprotein E4 and obesity acting as vulnerability factors. Cross-sectional findings suggest little, if any, relationship between OSA and impaired cognition in Apolipoprotein E ε4 (APOE4) allele carriers and non-carriers. OSA and nocturnal hypoxaemia have been found to contribute to cognitive decline in the elderly population, with associations observed between OSA parameters and decline in global cognitive function, processing speed, and executive function. Paroxysmal slow wave events (PSWEs) in OSA patients have been implicated in cognitive impairment, potentially due to blood-brain barrier dysfunction.
What are the sleep apnea comorbidities?5 answersObstructive sleep apnea (OSA) is associated with a wide range of comorbidities. These include cardiovascular complications such as arterial hypertension, pulmonary hypertension, chronic heart failure, arrhythmias, and myocardial infarction. Other comorbidities include cerebrovascular complications like strokes, metabolic conditions such as insulin resistance, obesity, diabetes mellitus, and metabolic syndrome, gastrointestinal issues like non-alcoholic liver disease, urinary complications like chronic renal failure, and neuropsychiatric complications. OSA also increases the risk of a variety of malignancies. Anxiety and depression are frequently reported comorbidities in patients with OSA, affecting over 40% of participants. Hypertension and diabetes mellitus are also common comorbidities in OSA patients. These comorbidities can have a significant impact on the health and quality of life of individuals with OSA, highlighting the importance of timely screening, diagnosis, and treatment of these conditions.
Do comorbidities affect the chemokine and cytokine profile in patients with obstructive sleep apnea?5 answersComorbidities in patients with obstructive sleep apnea (OSA) can affect the chemokine and cytokine profile. In patients with concomitant chronic obstructive pulmonary disease (COPD), there are increased levels of pro-inflammatory cytokines (CCL11, CD-40 ligand) and decreased levels of anti-inflammatory cytokine (IL-10). Patients with diabetes and OSA have increased levels of pro-inflammatory cytokines (IL-6, TRIAL). Obesity in OSA patients is associated with increased levels of both pro-inflammatory (IL-13) and anti-inflammatory (IL-1RA) cytokines. Hypertension in OSA patients is associated with increased levels of both pro-inflammatory (CCL3) and anti-inflammatory (IL-10) cytokines. Nocturnal hypoxemia, frequent episodes of desaturation, and increased daytime pCO2 contribute to the chronic inflammatory state in OSA patients, leading to increased levels of pro-inflammatory cytokines (CXCL1, PDGF-AB, TNF-α, and IL-15).
Is AFIB considered a comorbidity for Covid 19?3 answers

See what other people are reading

Can the PFF model accurately detect and classify sleep abnormalities?
5 answers
The PPG-based deep learning model, as discussed in, has shown promising results in accurately identifying sleep stages with moderate agreement to manual EEG-based scoring. Additionally, the study indemonstrates the effectiveness of a deep recurrent neural network in classifying sleep stages using PPG signals, achieving unprecedented performance in 4-class sleep stage classification. Furthermore, the study inhighlights the successful use of EEG sleep activity analysis combined with cross-frequency coupling (CFC) estimates to discriminate various sleep disorders. These findings collectively suggest that models utilizing PPG signals, EEG analysis, and deep learning techniques can indeed detect and classify sleep abnormalities with high accuracy, offering potential for improved diagnostic capabilities in identifying sleep disorders.
What is the current understanding of the effects of empagliflozin on ejection fraction in heart failure patients?
4 answers
Empagliflozin has shown promising effects on heart failure patients. Studies have demonstrated that empagliflozin improves quality of life, functional capacity, and reduces interleukin-6 levels in patients with heart failure and reduced ejection fraction (HFrEF). Additionally, in patients with heart failure and ejection fraction above 40%, empagliflozin has been found to reduce the risk of serious heart failure events and slow the decline in estimated glomerular filtration rate, regardless of baseline atrial fibrillation/flutter (AF). Furthermore, the use of empagliflozin in heart failure patients, irrespective of background diuretic use, has shown comparable improvements in cardiovascular outcomes and health status, suggesting a potential reduction in the need for diuretics.
What is the current state of international journal glycoside research?
5 answers
The current state of international journal glycoside research is dynamic and multifaceted. Glycosides, which are naturally occurring substances found in medicinal plants, exhibit significant therapeutic potential against cancer. Moreover, ongoing research highlights the importance of carbohydrates in cellular systems, emphasizing the role of glycoproteins and glycolipids in various cellular processes. Additionally, studies have shown the potential anti-diabetic activity of glycosides extracted from Samanea saman, indicating a promising avenue for the development of new phytochemicals for diabetes treatment. Understanding the structural and functional aspects of glycosylation, particularly in viral envelope proteins like the SARS-CoV-2 spike glycoprotein, is crucial for elucidating immune evasion mechanisms and designing effective therapeutic strategies against pathogens. This collective research underscores the diverse applications and significance of glycoside studies in current scientific endeavors.
How does the onset and progression of RBD phasic and RBD tonic differ from Parkinson's disease?
5 answers
The onset and progression of Rapid Eye Movement Sleep Behavior Disorder (RBD) in Parkinson's Disease (PD) exhibit distinct patterns. In PD, two subtypes were identified: subtype 1 with RBD and autonomic dysfunction as early manifestations, progressing to cognitive impairment and limbic degeneration; subtype 2 with cognitive impairment and limbic degeneration as early signs, advancing to RBD and locus coeruleus degeneration. Conversely, in RBD patients, EEG slowing during phasic REM sleep, particularly in central and occipital regions, was significantly higher in those who later developed neurodegenerative diseases, indicating a potential marker for phenoconversion. These findings highlight the differing trajectories of RBD and its association with neurodegenerative diseases like PD.
Is there any influence on hospitalized patients sleep duration and length of stay?
5 answers
Hospitalized patients often experience sleep disturbances due to various factors like noise, light exposure, and medical interventions, impacting their sleep duration. These disturbances can lead to poor sleep quality, affecting recovery and potentially prolonging the length of stay in hospitals. Factors such as noise levels exceeding recommended limits, nighttime awakenings for observations, and pain can disrupt patients' sleep patterns, contributing to longer hospital stays. Addressing these issues through interventions to improve sleep quality, reduce disturbances, and prioritize patients' sleep needs may help in enhancing recovery, potentially reducing the length of stay for hospitalized patients.
What are hypertensive heart disease symptoms?
5 answers
Hypertensive heart disease symptoms encompass a range of physical and mental manifestations. Patients may experience palpitations and angina, which are typical symptoms of heart disease. Left ventricular hypertrophy, increased ventricular stiffness, and various arrhythmias are common in hypertensive heart disease, potentially leading to heart failure if untreated. Additionally, hypertension-induced changes in the myocardium can result in symptoms like dizziness, headache, and tinnitus. Subtle signs such as tiredness or reduced physical capacity may indicate heart failure in hypertensive individuals. Furthermore, hypertensive heart disease can manifest as coronary insufficiency with angina pectoris, heart failure, and arrhythmias. These symptoms highlight the importance of early detection and management to prevent adverse outcomes associated with hypertensive heart disease.
What are symptoms of acute decompesated heart failure?
5 answers
Symptoms of acute decompensated heart failure (ADHF) include shortness of breath, extreme tiredness, inability to exercise, sleepiness. Patients with ADHF may also experience worsening renal function (WRF) and persistent congestion, leading to higher mortality and heart failure readmissions. Additionally, individuals with ADHF can present with symptoms such as palpitations, abdominal girth increase, lower extremity edema, orthopnea, and weight gain. Nurses play a crucial role in recognizing and managing ADHF symptoms, administering medications, monitoring therapy responses, and providing patient education to reduce hospital readmissions. Point-of-care lung ultrasound (LUS) has shown high sensitivity and specificity in diagnosing cardiogenic pulmonary edema in ADHF patients presenting with dyspnea, making it a valuable tool for prompt and accurate diagnosis.
How does attention deficit disorder affect academic performance in children?
10 answers
Attention Deficit Hyperactivity Disorder (ADHD) significantly impacts children's academic performance through various mechanisms. Children with ADHD exhibit symptoms such as inattention, impulsivity, and hyperactivity, which directly contribute to learning disorders and academic challenges. These symptoms often result in difficulties with concentration during class, leading to lower academic achievement and specific issues in working memory and mathematical learning disorders. The socioeconomic status (SES) does not significantly moderate the association between ADHD and academic performance, indicating that ADHD affects educational outcomes across different socioeconomic backgrounds. Furthermore, ADHD's impact on school performance varies across sex and parental education, with girls and children of highly educated parents experiencing a relatively larger deficit, although the absolute deficit is smaller for these groups. ADHD affects academic performance across all subjects, with the inattentive subtype being particularly detrimental. Medication and support in executive functioning deficit areas, such as working memory and organization, can improve schooling success. The academic trajectories of students with ADHD show they fall significantly behind their peers without mental disorders in reading, writing, and numeracy, with the gaps widening as they progress through school. Sleep problems associated with ADHD also negatively influence academic performance, highlighting the complex and multidirectional relationship between sleep and learning. Sleep parameters, including sleep time and night awakenings, predict academic and cognitive performance, underscoring the importance of addressing sleep issues in children with ADHD. Neuropsychological constructs such as executive dysfunction, delay aversion, and time perception are closely associated with ADHD symptoms and early academic performance, suggesting that interventions targeting these areas could mitigate learning difficulties. Despite having similar IQ levels to their peers without ADHD, children with ADHD have significantly lower academic performance, attributed to inattentiveness. This comprehensive overview underscores the multifaceted impact of ADHD on academic performance, necessitating a holistic approach to intervention that addresses the disorder's cognitive, behavioral, and sleep-related aspects.
What are the potential benefits and challenges of using low-power OTAs in biomedical devices?
5 answers
Low-power operational transconductance amplifiers (OTAs) offer significant advantages in biomedical devices. They enable long-term monitoring without disrupting sleep quality, as seen in ultrasonic devices for breathing activity monitoring. Additionally, low-power sensing technologies integrated with custom processors facilitate accurate signal analysis for medical information extraction, reducing energy consumption significantly compared to traditional CPU implementations. However, the adoption of miniaturized wireless biomedical devices (MWBDs) raises privacy and security concerns, necessitating secure designs with minimal resources while ensuring trust and user safety. Furthermore, wearable wireless sensors with low-power consumption are crucial for continuous monitoring of symptoms like asthmatic wheezing, emphasizing the importance of optimizing power consumption in digital signal processors for prolonged autonomy. Overall, leveraging low-power OTAs in biomedical devices presents benefits in energy efficiency and continuous monitoring capabilities, albeit accompanied by challenges related to security and signal processing optimization.
How does mouth breathing affect upper airway?
5 answers
Mouth breathing has significant implications for the upper airway. It can lead to increased airway obstruction and upper respiratory tract resistance, impacting conditions like obstructive sleep apnea (OSA). Mouth breathing during propofol-based intravenous anesthesia is associated with worsened oxygen desaturation and a higher degree of upper airway collapse, particularly involving the lateral pharyngeal wall and tongue base. Mouth breathing syndrome, often caused by nasal obstruction, allergic rhinitis, or adenoid hypertrophy, negatively affects various systems, including the respiratory, cardiovascular, and dental-skull-facial development. This breathing pattern can disrupt the balance of stomatognathic functions and lead to aberrant dental and maxillofacial development, emphasizing the importance of early identification and interdisciplinary management of mouth breathing syndrome.
Has atrial fibrillation, which increases stroke risk due to clots in the heart?
4 answers
Atrial fibrillation (AF) significantly increases the risk of stroke due to clot formation in the heart, leading to potential embolization to the brain and subsequent stroke. AF is associated with a 5-fold increased risk of ischemic stroke, with AF-related strokes often resulting in greater disability and mortality compared to strokes from other causes. Anticoagulation therapy is commonly used to prevent clot formation and reduce the occurrence of stroke in AF patients, although it comes with the risk of bleeding side effects. Despite appropriate anticoagulation therapy, a notable proportion of AF patients remain at a high residual stroke risk, necessitating further exploration of therapeutic options to mitigate this risk. The management of AF-related stroke involves complex decision-making to balance the risks and benefits of various treatment strategies.